: In this blog post, Vitalant research and medical affairs leaders reflect on the efforts that paved the way for more inclusive FDA blood donation eligibility guidelines that maintain the safety of the blood supply. Read more.
The Vitalant Innovation Center is a dedicated space to pioneer improvements and collect and prepare investigational blood products for research. Read more.
The San Francisco location of Vitalant’s research arm, Vitalant Research Institute (VRI), has moved to a new downtown San Francisco location at 360 Spear Street. The new location provides modern laboratory space for the Research Institute to continue advancing blood safety world-wide through scientific research, education, and the promotion of evidence-based policies.
Although there has been no evidence of transfusion-transmitted SARS-CoV-2 resulting in COVID-19 and the U.S. blood supply is extraordinarily safe, researchers from Vitalant, the American Red Cross, New York Blood Center and Bloodworks Northwest set out to assess to what degree SARS-CoV-2 could find its way into the blood supply from pre-symptomatic donors, and what if any impact it could have on patient care.
This summer, Vitalant Research Institute Director Emeritus and Vice President Michael Busch, M.D., Ph.D., became president of the International Society of Blood Transfusion.
Vitalant Research Institute’s tradition of excellence in lifesaving research will continue under new leadership, as founder and Director Michael Busch, M.D., Ph.D., begins to wind down his storied career and transitions to a new role as director emeritus of Vitalant Research Institute while continuing as a vice president of research and scientific programs within Vitalant. After an extensive external and internal search, Brian Custer, Ph.D., M.P.H, was selected to lead the Research Institute as director and senior vice president of research and scientific programs with Vitalant.